BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pai V, Pai N. Randomized, double-blind, comparative study of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal reflux disease. World J Gastroenterol 2007; 13(30): 4100-4102 [PMID: 17696229 DOI: 10.3748/wjg.v13.i30.4100]
URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4100.htm
Number Citing Articles
1
David Armstrong, Daniel Sifrim. New Pharmacologic Approaches in Gastroesophageal Reflux DiseaseGastroenterology Clinics of North America 2010; 39(3): 393 doi: 10.1016/j.gtc.2010.08.019
2
Miri Kim, Su Kyung Yu, Quoc-Ky Truong, Xuan-Lan Mai, Hyun Kyu Chung, Jong-Seong Kang, Kyeong Ho Kim. Determination of rabeprazole enantiomers in commercial tablets using immobilized cellulose-based stationary phaseArchives of Pharmacal Research 2017; 40(3): 373 doi: 10.1007/s12272-017-0896-z
3
Yu Kyung Cho, Myung-Gyu Choi, Hyojin Park, Ji Won Kim, Dong Ho Lee, Kwang Hyun Ko, Sang Gyun Kim, Hwoon-Yong Jung, Su Jin Hong, Yong Chan Lee, Si Hyung Lee. Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled TrialJournal of Neurogastroenterology and Motility 2021; 27(2): 223 doi: 10.5056/jnm19053
4
L N Rogoza, N F Salakhutdinov. Anti-ulcer agents: chemical aspect of solving the problemRussian Chemical Reviews 2015; 84(1): 98 doi: 10.1070/RCR4430
5
Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH, Seckin Bahar SEZGIN. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine2022; : 51 doi: 10.2174/9789815051780122010005
6
Na Cao, Lei Liu, Yuan-bin Hao, Li-li Sun, Qiao-gen Zou, Xing-ling Ma, Kai-he Xiong. Simultaneous determination of rabeprazole enantiomers and their four metabolites after intravenous administration in beagle dogs by a stereoselective HPLC-MS/MS method and its application in pharmacokinetic studiesAnalytical Methods 2016; 8(6): 1405 doi: 10.1039/C5AY03200H
7
Quan Zhou, Xiao-Feng Yan, Wen-Sheng Pan, Su Zeng. Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?World Journal of Gastroenterology 2008; 14(16): 2617-2619 doi: 10.3748/wjg.14.2617
8
Kenneth R. DeVault, Nicholas J. Talley. Insights into the future of gastric acid suppressionNature Reviews Gastroenterology & Hepatology 2009; 6(9): 524 doi: 10.1038/nrgastro.2009.125
9
Tae Jin Lee, Dohyun Kim, Jae Cheon Kim, Si Won Ro, Dong Hee Na. Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tabletsJournal of Pharmaceutical Investigation 2023; 53(2): 323 doi: 10.1007/s40005-022-00602-x
10
Yu Kyung Cho, Myung-Gyu Choi, Young-Tae Bak, Poong-Lyul Rhee, Sang Gyun Kim, Hoon-Yong Jung, Sang Young Seol. Efficacy of S-Pantoprazole 20 mg Compared with Pantoprazole 40 mg in the Treatment of Reflux Esophagitis: A Randomized, Double-Blind Comparative TrialDigestive Diseases and Sciences 2012; 57(12): 3189 doi: 10.1007/s10620-012-2297-y
11
Gergely Dombi, Levente Tyukodi, Máté Dobó, Gergely Molnár, Zsuzsanna Rozmer, Zoltán-István Szabó, Béla Fiser, Gergő Tóth. Enantioselective Binding of Proton Pump Inhibitors to Alpha1-Acid Glycoprotein and Human Serum Albumin—A Chromatographic, Spectroscopic, and In Silico StudyInternational Journal of Molecular Sciences 2024; 25(19): 10575 doi: 10.3390/ijms251910575
12
David Armstrong, Daniel Sifrim. New Pharmacologic Approaches in Gastroesophageal Reflux DiseaseThoracic Surgery Clinics 2011; 21(4): 557 doi: 10.1016/j.thorsurg.2011.09.005
13
Rajendra Kanakia, Suresh Jain. Ten mg dexrabeprazole daily is as effective as 20 mg dexrabeprazole dailyWorld Journal of Gastroenterology 2008; 14(28): 4586-4587 doi: 10.3748/wjg.14.4586
14
Peter J Kahrilas, Colin W Howden, Nesta Hughes. Response of Regurgitation to Proton Pump Inhibitor Therapy in Clinical Trials of Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology 2011; 106(8): 1419 doi: 10.1038/ajg.2011.146
15
Shuchi Dixit, Rituraj Dubey, Ravi Bhushan. Normal and polar‐organic‐phase high‐performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro‐methylated cellulose‐based chiral stationary phase and determination of dexrabeprazoleBiomedical Chromatography 2014; 28(1): 112 doi: 10.1002/bmc.2915
16
Stefano Pallotta, Fabio Pace, Silvia Marelli. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related diseaseExpert Review of Gastroenterology & Hepatology 2008; 2(4): 509 doi: 10.1586/17474124.2.4.509
17
Jianman Guo, Xiaoyuan Ma, Fanlong Bu, Jian Wang, Jie Sun, Rui Zhang. Improved quantitative determination of (R)- and (S)‐rabeprazole sodium and its metabolites in rat plasma by LC-MS/MS and its application to a toxicokinetic studyJournal of Chromatography B 2024; 1232: 123969 doi: 10.1016/j.jchromb.2023.123969
18
Sukhbir K Shahid. Novel Anti -Helicobacter Pylori Therapies Pharmaceutical Patent Analyst 2014; 3(4): 411 doi: 10.4155/ppa.14.27
19
Lu‐Ning Sun, Yi‐Wen Shen, Yu‐Wen Ying, Duo Li, Teng‐Fei Li, Xue‐Hui Zhang, Ping Zhao, Li Ding, Yong‐Qing Wang. Stereoselective pharmacokinetics of (R)‐(+)‐ and (S)‐(−)‐rabeprazole in human using chiral LC‐MS/MS after administration of rabeprazole sodium enteric‐coated tabletChirality 2018; 30(12): 1277 doi: 10.1002/chir.23022
20
Chong Su, Hong Yang, Xiangjun Meng, J. Paul Fawcett, Jianming Cao, Yan Yang, Jingkai Gu. Determination of rabeprazole enantiomers in dog plasma by supercritical fluid chromatography tandem mass spectrometry and its application to a pharmacokinetic studyJournal of Separation Science 2017; 40(4): 1010 doi: 10.1002/jssc.201601232
21
Zaahira Aumeeruddy-Elalfi, Ismaël Saïd Ismaël, Muzzammil Hosenally, Gokhan Zengin, Mohamad Fawzi Mahomoodally. Essential oils from tropical medicinal herbs and food plants inhibit biofilm formation in vitro and are non-cytotoxic to human cells3 Biotech 2018; 8(9) doi: 10.1007/s13205-018-1413-x
22
Tommy Andersson, Lars Weidolf. Stereoselective Disposition of Proton??Pump InhibitorsClinical Drug Investigation 2008; 28(5): 263 doi: 10.2165/00044011-200828050-00001
23
Alex Mejia, Walter K Kraft. Acid peptic diseases: pharmacological approach to treatmentExpert Review of Clinical Pharmacology 2009; 2(3): 295 doi: 10.1586/ecp.09.8
24
Long Nguyen, John Birk. Current and Prospective Pharmacotherapies in Gastroesophageal Reflux DiseaseClinical Medicine. Therapeutics 2009; 1 doi: 10.4137/CMT.S2744
25
Feng Liu, Chao Shou, Qiang Geng, Chen Zhao, Jianhe Xu, Huilei Yu. A Baeyer-Villiger monooxygenase from Cupriavidus basilensis catalyzes asymmetric synthesis of (R)-lansoprazole and other pharmaco-sulfoxidesApplied Microbiology and Biotechnology 2021; 105(8): 3169 doi: 10.1007/s00253-021-11230-0
26
Yan‐hui Gao, Jia‐xing Xu, Zhong‐xue Su, Li Song, Hong‐xiang Lou. The chiral bioconversion and preclinical pharmacokinetic analysis of (R)‐(+)‐rabeprazole in beagle dogs by HPLC and HPLC‐MS/MSBiomedical Chromatography 2013; 27(11): 1380 doi: 10.1002/bmc.2932